So much uncertainty exists, but global indices are still only a few percentage points off their highest-ever levels.
If pent-up need leads to a patient tsunami, practices could struggle.
Abano is considering whether to capital raise $50m-$70m, instead of accepting BGH's leaked bid.
Financial advisers’ lobby welcomes FMA’s proposals for overhaul of regulatory regime.
Institute of Directors pushed for changes similar to Australia’s, to deter class action.
Kiwi businessmen ride in to buy NZ and Australian magazine stable, but detail of deal unknown.
Dunedin-developed home bladder cancer screening will now be available to millions of US patients.
Placement, share purchase plan will go alongside new debt facilities, suspension of dividends.
Regal has sold down its stake in the struggling company seven times since December.
THL’s CFO and COO have both resigned from the company.
